Eisai Reimbursement Resources

Eisai offers drug-specific reimbursement assistance to patients taking Halaven or Lenvima (Table).

Eisai Reimbursement Resources

Eisai Reimbursement Resources offers a $0 Co-Pay Program, a Patient Assistance Program, and the Lenvima Dose Exchange Program.

$0 Co-Pay Program

The $0 Co-Pay Program provides assistance for patients with commercial insurance who have been prescribed Halaven or Lenvima for an approved indication. The program is not available to patients enrolled in state or federal healthcare programs, including Medicare, Medicaid, Medigap, Veterans Administration, Department of Defense, or TRICARE.

Patient Assistance Program

Halaven and Lenvima may be available at low cost or no cost to financially needy patients who meet the program’s eligibility criteria, including US residency, income status, and site-of-service specifications. Coverage and payment depend on the patient’s insurance plan.

Lenvima Dose Exchange Program

Eligible patients who require a dose reduction can exchange up to 15 unused doses for the same number of doses at the reduced dose strength at no additional cost.

TABLE Eisai Oncology Drugs